Genotype‐driven asthma prescribing of inhaled corticosteroids and long‐acting β2‐agonist: A cost‐effectiveness analysis
Article in Pediatric Pulmonology (April 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Cost-utility analysis of prenatal supplementation with long-chain n-3 fatty acids to reduce the incidence of wheezing and asthma in neonates
Article in Journal of Asthma (March 2024)
Economic evidence supports the cost savings of sputum eosinophil counts to guide the treatment of pediatrics patients with persistent asthma: implications for clinical practice guidelines in middle-income countries
Article in Journal of Asthma (December 2023)